TABLE 3b.
Janssen | Moderna | Pfizer-BioNTech | |
---|---|---|---|
CTC | RR 95% CI | RR 95% CI | RR 95% CI |
Allergic | 8.57 [8.15–9.01] | 65.58 [62.62–68.68] | 39.26 [37.47–41.13] |
Arrythmia | 17.77 [15.48–20.39] | 56.87 [49.77–64.99] | 70.80 [61.98–80.88] |
Haematological | 27.56 [14.19–53.55] | 102.01 [53.28–195.30] | 111.12 [58.07–212.65] |
Cardiovascular | 34.70 [27.15–44.34] | 132.48 [104.13–168.53] | 154.38 [121.37–196.35] |
Coagulation | 58.80 [37.04–93.34] | 115.40 [72.94–182.59] | 132.97 [84.08–210.29] |
Constitutional | 18.47 [17.37–19.64] | 83.55 [78.74–88.66] | 68.36 [64.41–72.55] |
Dermatological | 1.60 [1.50–1.71] | 39.56 [37.74–41.47] | 10.17 [9.67–10.69] |
Gastrointestinal | 14.47 [13.47–15.54] | 62.41 [58.27–66.85] | 57.76 [53.92–61.87] |
Haemorraghe | 16.44 [10.82–24.97] | 52.62 [35.13–78.82] | 61.74 [41.26–92.39] |
Neurological | 13.27 [12.52–14.06] | 47.04 [44.51–49.72] | 54.57 [51.64–57.67] |
Ocular | 13.03 [11.20–15.16] | 40.76 [35.26–47.12] | 46.51 [40.25–53.75] |
Localised pain | 3.95 [3.63–4.31] | 37.56 [34.91–40.41] | 19.57 [18.16–21.09] |
Non-localised pain | 9.19 [8.84–9.55] | 43.79 [42.24–45.40] | 38.21 [36.85–39.62] |
Pulmonary | 18.06 [16.20–20.15] | 70.69 [63.62–78.56] | 85.32 [76.80–94.80] |
Renal/Genitourinary | 21.16 [12.10–37.00] | 99.07 [57.63–170.32] | 113.13 [65.84–194.37] |
Sexual organs | 97.04 [51.66–182.27] | 345.89 [184.90–647.06] | 572.52 [306.24–1070.35] |
Thrombosis | 417.54 [145.56–1197.72] | 659.40 [230.06–1889.96] | 777.70 [271.39–2228.54] |
Other reactions | 9.10 [8.97–9.22] | 45.71 [45.12–46.30] | 44.14 [43.58–44.71] |